Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability.
about
PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in miceMechanistic basis and clinical relevance of the role of transforming growth factor-β in cancerComprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.MicroRNA-200b is downregulated in colon cancer budding cells.EMT is the dominant program in human colon cancer.Neuropilin-2 expression promotes TGF-β1-mediated epithelial to mesenchymal transition in colorectal cancer cells.Cancerous stem cells: deviant stem cells with cancer-causing misbehavior.Increase of α-SMA(+) and CK (+) cells as an early sign of epithelial-mesenchymal transition during colorectal carcinogenesis.Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancerE-cadherin and the cytoskeletal network in colorectal cancer development and metastasis.Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers.Genetic alterations in colorectal cancer.Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo.Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer.Widespread FRA1-dependent control of mesenchymal transdifferentiation programs in colorectal cancer cells.β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.Oncogenic KRAS regulates BMP4 expression in colon cancer cell lines.Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells.Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes.Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patientsPrognostic value of colorectal cancer biomarkers.Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.Adrenomedullin is a therapeutic target in colorectal cancer.Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β via EMT inhibition in colorectal cancerTwist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cellsEpithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer.Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.Identification of the novel differentiation marker MS4A8B and its murine homolog MS4A8A in colonic epithelial cells lost during neoplastic transformation in human colonThe iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1).Rotavirus-induced miR-142-5p elicits proviral milieu by targeting non-canonical transforming growth factor beta signalling and apoptosis in cells.TrkC promotes colorectal cancer growth and metastasis.Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts.Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers.Genetic and epigenetic events generate multiple pathways in colorectal cancer progression.The role of tumour stroma in colorectal cancer invasion and metastasis.Aquaporin-3 in Cancer.BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma.Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD-L1 (CD274)-expression: Possible roles of tumour micro environmental factors for CD274 expression.
P2860
Q24337364-7E5D13DE-7019-44B1-B40E-2D5397D1A5E6Q26771386-60A0389A-2C26-4363-A4BF-09A2425A818FQ31092607-C37589C2-8B69-4603-88FC-880D805EC9D0Q33732204-C52B668F-52D1-4A3C-B7AF-C72BD89B71EBQ33798739-065F286D-A1AF-4C10-94E1-8FD32DFBF2A8Q33957987-FA8D5C27-8751-4282-8C7C-1B6303C4CB75Q33999466-54548134-9850-424E-9171-C851BE7C7CF2Q34018064-D436DBA4-644F-4C80-A42E-2A6DEDF45C5BQ34067225-2EEB7BAA-AE20-466A-95C5-B61B5F7CD8D7Q34241196-D07908CD-B446-42F9-B7F0-EFCD0E6E361FQ34460444-07419E66-6491-4BE3-A829-53CC9CCD11B5Q34638183-7A6C06F1-FF35-454F-9213-40186E104FB4Q34963434-F6DB2978-5006-4D34-8A6B-A5B241C6A373Q35037258-F842E615-6CA2-4106-BFB1-CBE7B2A64E9AQ35128358-EDF651DF-D60D-455C-B791-B503E51A9675Q35585837-5CE574BB-441A-4B93-B2BE-5F551F23EE48Q35994053-B9979888-45E0-483C-AC23-B061E1A0EDE6Q36531360-BA60C0D1-82F0-411C-98E7-458139D7843BQ36660380-7229FE71-4F0F-47EA-843D-46BAD52E3602Q37057045-729AE0B9-D9A9-47E6-A62E-A46DB429115CQ37132721-6DEBE8F2-9B73-47EB-9AC7-47D17CB5A7E7Q37147318-94155671-4BCC-4E47-BB05-4B8F06C1594FQ37593331-98303498-8E1C-48D1-AA60-BF09DE531FC5Q37614604-042A3408-9F3C-4520-851C-010F094D51FFQ37636754-9CD814D2-4C0E-4963-AE2D-3FA6D7E5F799Q37840946-D5B2655A-647D-42A7-A3D7-5670AAFE12B3Q38227766-DB233821-76D8-42BA-8B18-9B766015E552Q38457404-085B85ED-C303-4A62-AF51-F45BC71BC406Q38696296-9C839971-1094-4708-87C8-523627CB7861Q39205168-8AE2B3E5-2B65-429A-9609-D1884BB2EE73Q39372971-404439B0-D9ED-4543-97FA-A382065517E6Q40908426-9A52B08C-A95C-403C-AF67-C62A3679F1D7Q41093090-156C2F91-6A78-4C8A-8809-076A848DED6DQ41135157-E7D58032-A3E4-4C66-9E33-63B5CB7DD61EQ41602027-14DBBC1D-AAF8-4AED-A7DD-6E819CB36AA9Q42257482-C1E1C434-8BEF-47BC-B8F2-5DD52EFA3F7CQ42576948-A852CCAB-A8B3-4720-8FD0-E87C59F27973Q44895851-2A47E8B8-FC19-4205-8310-18D41C2FC84CQ45083311-CCAE0EC5-EC9A-4A78-BF67-8B97219F82D3Q47127609-EF751662-D5CE-4B1B-A69D-A7FBAD931318
P2860
Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Epithelial to mesenchymal tran ...... th microsatellite instability.
@ast
Epithelial to mesenchymal tran ...... th microsatellite instability.
@en
type
label
Epithelial to mesenchymal tran ...... th microsatellite instability.
@ast
Epithelial to mesenchymal tran ...... th microsatellite instability.
@en
prefLabel
Epithelial to mesenchymal tran ...... th microsatellite instability.
@ast
Epithelial to mesenchymal tran ...... th microsatellite instability.
@en
P2093
P2860
P1433
P1476
Epithelial to mesenchymal tran ...... th microsatellite instability.
@en
P2093
A John Iafrate
Daniel C Chung
David Berger
Do-Youn Park
Hirotoshi Kikuchi
Lawrence R Zukerberg
Maria S Pino
P2860
P304
P356
10.1053/J.GASTRO.2009.12.010
P407
P577
2009-12-21T00:00:00Z